BDF
CL icon

Balasa Dinverno & Foltz’s Colgate-Palmolive CL Stock Holding History

Balasa Dinverno & Foltz’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$566K Sell
8,062
-1,667
-17% -$131K 0.04% 187
2022
Q2 		$780K Buy
9,729
+37
+0.4% +$2.89K 0.05% 149
2022
Q1 		$735K Sell
9,692
-387
-4% -$30.7K 0.05% 157
2021
Q4 		$860K Sell
10,079
-4,578
-31% -$357K 0.06% 145
2021
Q3 		$1.11M Sell
14,657
-3,860
-21% -$307K 0.08% 113
2021
Q2 		$1.51M Sell
18,517
-1,346
-7% -$110K 0.11% 92
2021
Q1 		$1.57M Buy
19,863
+1,366
+7% +$107K 0.13% 84
2020
Q4 		$1.58M Buy
18,497
+7,697
+71% +$636K 0.13% 76
2020
Q3 		$833K Buy
10,800
+4,078
+61% +$311K 0.08% 112
2020
Q2 		$492K Sell
6,722
-2,090
-24% -$148K 0.05% 129
2020
Q1 		$585K Buy
8,812
+5,323
+153% +$375K 0.07% 120
2019
Q4 		$240K Sell
3,489
-121
-3% -$8.25K 0.03% 233
2019
Q3 		$265K Buy
3,610
+74
+2% +$5.37K 0.03% 205
2019
Q2 		$253K Sell
3,536
-130
-4% -$9.23K 0.03% 207
2019
Q1 		$251K Buy
3,666
+164
+5% +$10.6K 0.03% 211
2018
Q4 		$208K Sell
3,502
-162
-4% -$10.1K 0.03% 213
2018
Q3 		$245K Buy
3,664
+492
+16% +$32.8K 0.03% 214
2018
Q2 		$206K Sell
3,172
-2,422
-43% -$158K 0.03% 213
2018
Q1 		$401K Sell
5,594
-528
-9% -$38K 0.06% 140
2017
Q4 		$462K Sell
6,122
-1,495
-20% -$109K 0.07% 124
2017
Q3 		$555K Buy
7,617
+1,592
+26% +$115K 0.09% 108
2017
Q2 		$447K Buy
6,025
+1,486
+33% +$110K 0.07% 130
2017
Q1 		$332K Buy
4,539
+1,455
+47% +$102K 0.06% 144
2016
Q4 		$202K Buy
3,084
+5
+0.2% +$343 0.03% 184
2016
Q3 		$228K Sell
3,079
-58
-2% -$4.29K 0.04% 163
2016
Q2 		$230K Sell
3,137
-2,149
-41% -$153K 0.04% 158
2016
Q1 		$373K Sell
5,286
-173
-3% -$11.5K 0.07% 111
2015
Q4 		$364K Sell
5,459
-84
-2% -$5.59K 0.06% 125
2015
Q3 		$352K Sell
5,543
-125
-2% -$8.17K 0.06% 117
2015
Q2 		$371K Sell
5,668
-1,011
-15% -$68.6K 0.06% 119
2015
Q1 		$463K Sell
6,679
-128
-2% -$8.85K 0.07% 92
2014
Q4 		$471K Buy
6,807
+108
+2% +$7.29K 0.07% 97
2014
Q3 		$437K Buy
6,699
+457
+7% +$30.1K 0.07% 93
2014
Q2 		$426K Sell
6,242
-7
-0.1% -$469 0.05% 91
2014
Q1 		$405K Buy
6,249
+874
+16% +$55.1K 0.05% 92
2013
Q4 		$350K Buy
5,375
+15
+0.3% +$960 0.05% 94
2013
Q3 		$318K Sell
5,360
-285
-5% -$16.9K 0.05% 94
2013
Q2 		$323K Buy
+5,645
New +$335K 0.06% 90

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Balasa Dinverno & Foltz's CL Position: Q3 2022 in Review

Balasa Dinverno & Foltz reduced its Colgate-Palmolive (CL) stake by 17% in Q3 2022, selling an estimated $131K and leaving 8,062 shares worth $566K. The position accounts for 0.04% of the portfolio, ranked #187.

Balasa Dinverno & Foltz first reported a position in CL in Q2 2013 and has held it in 38 quarters since. The position peaked at $1.58M in Q4 2020. 1,614 funds tracked by Wall St. Rank hold CL as of Q3 2022.

  • Balasa Dinverno & Foltz held 8,062 shares of Colgate-Palmolive worth $566K as of Q3 2022.
  • Balasa Dinverno & Foltz sold 1,667 Colgate-Palmolive shares in Q3 2022, an estimated $131K.
  • Colgate-Palmolive made up 0.04% of Balasa Dinverno & Foltz's portfolio in Q3 2022, its #187 holding.
  • Balasa Dinverno & Foltz first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 38 quarters since.
  • Balasa Dinverno & Foltz's Colgate-Palmolive position peaked at $1.58M in Q4 2020.
  • 1,614 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2022.

Based on Balasa Dinverno & Foltz's 13F filing for Q3 2022, filed 25 Oct 2022.